BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10602891)

  • 41. Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
    Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Papavramidis S; Bousoulegas A; Basdanis G; Giannoulis E; Dokmetzioglou J; Katsohis C; Nenopoulou E; Karvounis N; Briassoulis E; Aravantinos G; Kosmidis P; Skarlos D; Pavlidis N
    Oncology; 2000 Apr; 58(3):227-36. PubMed ID: 10765125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
    André T; Meyerhardt J; Iveson T; Sobrero A; Yoshino T; Souglakos I; Grothey A; Niedzwiecki D; Saunders M; Labianca R; Yamanaka T; Boukovinas I; Vernerey D; Meyers J; Harkin A; Torri V; Oki E; Georgoulias V; Taieb J; Shields A; Shi Q
    Lancet Oncol; 2020 Dec; 21(12):1620-1629. PubMed ID: 33271092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? Against the proposal.
    Köhne CH
    Lancet Oncol; 2006 Jun; 7(6):516-7. PubMed ID: 16767832
    [No Abstract]   [Full Text] [Related]  

  • 44. Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer.
    Windle R; Bell PR; Shaw D
    Br J Surg; 1987 Jul; 74(7):569-72. PubMed ID: 3304518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.
    Touil Y; Igoudjil W; Corvaisier M; Dessein AF; Vandomme J; Monté D; Stechly L; Skrypek N; Langlois C; Grard G; Millet G; Leteurtre E; Dumont P; Truant S; Pruvot FR; Hebbar M; Fan F; Ellis LM; Formstecher P; Van Seuningen I; Gespach C; Polakowska R; Huet G
    Clin Cancer Res; 2014 Feb; 20(4):837-46. PubMed ID: 24323901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant chemotherapy in colon cancer: what is the evidence?
    Haydon A
    Intern Med J; 2003 Mar; 33(3):119-24. PubMed ID: 12603585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
    Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen CM; Ungerleider JS; Emerson WA; Tormey DC; Glick JH
    J Clin Oncol; 1995 Dec; 13(12):2936-43. PubMed ID: 8523058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological alterations induced by adjuvant treatment of postoperative colon carcinoma Duke's B or C with levamisole in combination with 5-FU.
    De Brabander M; Vandebroek J; Wassenaar H; De Crée J; Baisier A; Demoen B; De Ridder R; Jagers E; Roels V; Vogels O
    Anticancer Res; 1995; 15(5B):2271-7. PubMed ID: 8572636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant therapy of colorectal cancer.
    Kemeny N; Saltz L; Cohen A
    Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer: A Systematic Review and Meta-analysis.
    Boyne DJ; Cuthbert CA; O'Sullivan DE; Sajobi TT; Hilsden RJ; Friedenreich CM; Cheung WY; Brenner DR
    JAMA Netw Open; 2019 May; 2(5):e194154. PubMed ID: 31099875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant radiation therapy for colon cancer.
    Minsky BD
    Cancer Treat Rev; 1995 Sep; 21(5):407-14. PubMed ID: 8556716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
    O'Connell MJ; Laurie JA; Kahn M; Fitzgibbons RJ; Erlichman C; Shepherd L; Moertel CG; Kocha WI; Pazdur R; Wieand HS; Rubin J; Vukov AM; Donohue JH; Krook JE; Figueredo A
    J Clin Oncol; 1998 Jan; 16(1):295-300. PubMed ID: 9440756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An overview of adjuvant systemic chemotherapy for colon cancer.
    Andre T; de Gramont A;
    Clin Colorectal Cancer; 2004 Jun; 4 Suppl 1():S22-8. PubMed ID: 15212702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision.
    Donada M; Bonin S; Barbazza R; Pettirosso D; Stanta G
    BMC Gastroenterol; 2013 Feb; 13():36. PubMed ID: 23446022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database.
    Salem ME; Yin J; Goldberg RM; Pederson LD; Wolmark N; Alberts SR; Taieb J; Marshall JL; Lonardi S; Yoshino T; Kerr RS; Yothers G; Grothey A; Andre T; De Gramont A; Shi Q
    Ann Oncol; 2020 Apr; 31(4):480-486. PubMed ID: 32085892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? For the proposal.
    Sobrero A
    Lancet Oncol; 2006 Jun; 7(6):515-6. PubMed ID: 16750502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Adjuvant therapy of colon cancer. State of the art and future perspectives].
    Barni S; Cascinu S; Foa P; Frontini L; Labianca R; Luporini G; Mandalà M; Martignoni G; Pancera G; Sobrero A; Zaniboni A
    Tumori; 1999; 85(3):A1-6. PubMed ID: 10426137
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04].
    Schumacher K
    Strahlenther Onkol; 2000 May; 176(5):239-40. PubMed ID: 10847122
    [No Abstract]   [Full Text] [Related]  

  • 60. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
    Medinger M; Steinbild S; Mross K
    Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.